{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:32:33Z","timestamp":1785717153680,"version":"3.56.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T00:00:00Z","timestamp":1297728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00296-011-1808-z","type":"journal-article","created":{"date-parts":[[2011,2,14]],"date-time":"2011-02-14T10:13:25Z","timestamp":1297678405000},"page":"1533-1539","source":"Crossref","is-referenced-by-count":43,"title":["Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study"],"prefix":"10.1007","volume":"32","author":[{"given":"Martin","family":"Feuchtenberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kleinert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Roll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Christina","family":"Scharbatke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Ostermeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard E.","family":"Voll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Tony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,15]]},"reference":[{"issue":"7","key":"1808_CR1","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/rheumatology\/kem076","volume":"46","author":"S Bernatsky","year":"2007","unstructured":"Bernatsky S, Hudson M, Suissa S (2007) Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology (Oxford) 46(7):1157\u20131160","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"1808_CR2","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.10524","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran MF et al (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 46(9):2287\u20132293","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1808_CR3","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1002\/art.21386","volume":"52","author":"J Listing","year":"2005","unstructured":"Listing J et al (2005) Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum 52(11):3403\u20133412","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1808_CR4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.mad.2009.07.003","volume":"130","author":"T Peters","year":"2009","unstructured":"Peters T et al (2009) Reactive oxygen intermediate-induced pathomechanisms contribute to immunosenescence, chronic inflammation and autoimmunity. Mech Ageing Dev 130(9):564\u2013587","journal-title":"Mech Ageing Dev"},{"issue":"3","key":"1808_CR5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0049-0172(99)80024-9","volume":"29","author":"SA Older","year":"1999","unstructured":"Older SA et al (1999) Can immunization precipitate connective tissue disease? Report of five cases of systemic lupus erythematosus and review of the literature. Semin Arthritis Rheum 29(3):131\u2013139","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"1808_CR6","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/rheumatology\/keq183","volume":"49","author":"JF Rahier","year":"2010","unstructured":"Rahier JF et al (2010) Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford) 49(10):1815\u20131827","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1808_CR7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/rheumatology\/ken436","volume":"48","author":"S Borte","year":"2009","unstructured":"Borte S et al (2009) Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept. Rheumatology (Oxford) 48(2):144\u2013148","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"1808_CR8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/ard.2007.077552","volume":"67","author":"LB Gelinck","year":"2008","unstructured":"Gelinck LB et al (2008) The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis 67(5):713\u2013716","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1808_CR9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/rheumatology\/kei193","volume":"45","author":"MC Kapetanovic","year":"2006","unstructured":"Kapetanovic MC et al (2006) Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford) 45(1):106\u2013111","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1808_CR10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/art.25033","volume":"62","author":"S Assen van","year":"2010","unstructured":"van Assen S et al (2010) Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis Rheum 62(1):75\u201381","journal-title":"Arthritis Rheum"},{"issue":"32","key":"1808_CR11","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1016\/S0264-410X(01)00217-1","volume":"19","author":"C Cornu","year":"2001","unstructured":"Cornu C et al (2001) Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials. Vaccine 19(32):4780\u20134790","journal-title":"Vaccine"},{"issue":"1","key":"1808_CR12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/archinte.167.1.53","volume":"167","author":"KA Spaude","year":"2007","unstructured":"Spaude KA et al (2007) Influenza vaccination and risk of mortality among adults hospitalized with community-acquired pneumonia. Arch Intern Med 167(1):53\u201359","journal-title":"Arch Intern Med"},{"issue":"1","key":"1808_CR13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/art.25034","volume":"62","author":"CO Bingham 3rd","year":"2009","unstructured":"Bingham CO 3rd (2009) Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial. Arthritis Rheum 62(1):64\u201374","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1808_CR14","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.21778","volume":"54","author":"P Emery","year":"2006","unstructured":"Emery P et al (2006) The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. Arthritis Rheum 54(5):1390\u20131400","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1808_CR15","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1136\/ard.2007.071878","volume":"66","author":"LB Gelinck","year":"2007","unstructured":"Gelinck LB et al (2007) Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab. Ann Rheum Dis 66(10):1402\u20131403","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1808_CR16","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/ard.2007.077461","volume":"67","author":"S Oren","year":"2008","unstructured":"Oren S et al (2008) Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response. Ann Rheum Dis 67(7):937\u2013941","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1808_CR17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/art.25033","volume":"62","author":"S Assen van","year":"2009","unstructured":"van Assen S et al (2009) Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis Rheum 62(1):75\u201381","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1808_CR18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/08916930500144484","volume":"38","author":"DA Geier","year":"2005","unstructured":"Geier DA, Geier MR (2005) A case-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity 38(4):295\u2013301","journal-title":"Autoimmunity"},{"issue":"9","key":"1808_CR19","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1002\/art.22025","volume":"54","author":"SB Cohen","year":"2006","unstructured":"Cohen SB et al (2006) Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 54(9):2793\u20132806","journal-title":"Arthritis Rheum"},{"issue":"24","key":"1808_CR20","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1056\/NEJMoa061850","volume":"355","author":"SE Ohmit","year":"2006","unstructured":"Ohmit SE et al (2006) Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 355(24):2513\u20132522","journal-title":"N Engl J Med"},{"issue":"3","key":"1808_CR21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00001432-200406000-00002","volume":"17","author":"KM Posfay-Barbe","year":"2004","unstructured":"Posfay-Barbe KM, Wald ER (2004) Pneumococcal vaccines: do they prevent infection and how? Curr Opin Infect Dis 17(3):177\u2013184","journal-title":"Curr Opin Infect Dis"},{"issue":"7","key":"1808_CR22","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/rheumatology\/kel104","volume":"45","author":"WA Fahy","year":"2006","unstructured":"Fahy WA et al (2006) Pneumococcal and influenza vaccination in patients with rheumatic conditions and receiving DMARD therapy. Rheumatology (Oxford) 45(7):912\u2013913","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"1808_CR23","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/art.24873","volume":"61","author":"LJ Ledwich","year":"2009","unstructured":"Ledwich LJ et al (2009) Improved influenza and pneumococcal vaccination in rheumatology patients taking immunosuppressants using an electronic health record best practice alert. Arthritis Rheum 61(11):1505\u20131510","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1808_CR24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.clim.2006.08.016","volume":"122","author":"T Vallerskog","year":"2007","unstructured":"Vallerskog T et al (2007) Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Clin Immunol 122(1):62\u201374","journal-title":"Clin Immunol"},{"issue":"3","key":"1808_CR25","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3899\/jrheum.090856","volume":"37","author":"RF Vollenhoven van","year":"2010","unstructured":"van Vollenhoven RF et al (2010) Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials. J Rheumatol 37(3):558\u2013567","journal-title":"J Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-1808-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-011-1808-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-1808-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T10:45:43Z","timestamp":1559990743000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-011-1808-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,15]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["1808"],"URL":"https:\/\/doi.org\/10.1007\/s00296-011-1808-z","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,15]]}}}